Get started
- Over 450 GP practices use uMed to participate in clinical research
- Enroled 6,000+ patients in clinical research
- Only 10 minutes of your time is required to participate in a study
- Generate additional revenue for your practice
Join the uMed Research Network
Play your part in advancing medical research.
Set-up support
If you would like to join our Research Network
Fill in your details on the right to book a call with our support team so we can discuss requirements for your specific organisation and help you to get started with the onboarding process.
If you are part of an ongoing uMed-supported study and would like support, please contact us here.
Book a meeting with our support team to discuss set-up with the uMed platform.
An error occurred. Please reload an try again.
Get started
- 400 GP practices use uMed to participate in clinical research
- Enrolled 4,000+ patients in clinical research
- Only 10 minutes of your time is required to participate in a study
- Generate additional revenue for your practice
Why do we need your practice ODS code?
We need to verify your practice’s unique code created by the Organisation Data Service within NHS Digital.
This is used to identify organisations across health and social care to ensure we have the right information.
You may need to ask your practice manager for this.
Why do we need your practice details?
We need to verify your practice’s unique code created by the Organisation Data Service within NHS Digital.
This is used to identify organisations across health and social care to ensure we have the right information.
Why do we need your practice ODS code?
We need to verify your practice’s unique code created by the Organisation Data Service within NHS Digital.
This is used to identify organisations across health and social care to ensure we have the right information.
EHR system
uMed has agreements with EHR providers in the UK, such as EMIS and SystmOne.
EHR system
uMed has agreements with EHR providers in the UK, such as EMIS and SystmOne.
If your practice is registered with the EMIS system, please enter your CBD code.
Why do we need your CBD code?
In order for us to activate the EMIS agreement, we need your EMIS CBD code, this is a unique number given to you by EMIS.
You may know it as your EMIS customer number.
Who would know the CBD code?
You should be able to find this on EMIS Web or alternatively, contact your practice manager.
Last step…
We’ve gone above and beyond to exceed data security requirements.
- We conform to the requirements of General Data Protection Regulation (UK GDPR) as well as the NHS Data Protection & Security Toolkit
- ISO27001:2013, ISO9001:2015 compliant and Cyber Essentials Plus Certified
- Our Data Processing Agreement has been independently reviewed by Wessex CRN legal team
- We have Data Processing Agreements in place with 400 GP practices in the UK
Want more information? Download our Information governance pack here.
If you have any Information Governance related questions, view our FAQ’s here or alternatively, speak to a member of our support team.
We want you to feel secure that your data is being handled transparently, so we ask each practice to sign our Data Processing Agreement.
Please provide the details of the person that will be responsible for signing the data processing agreement and we will send them the document by email.
EHR system
uMed has agreements with EHR providers in the UK, such as EMIS and SystmOne.
EHR system
uMed has agreements with EHR providers in the UK, such as EMIS and SystmOne.
If your practice is registered with the SystmOne (TPP), please provide the following details.
Thank you
Thank you for registering your interest. We will be in touch soon.
What’s next?
Thank you for requesting the uMed Data Processing Agreement, a DocuSign agreement has been sent to the stated person responsible for signing this agreement.
Upon digitally signing this agreement, our team will be in touch with a training video and password.
Your practice will then be able to start participating in a uMed study.
You can find more information about the interventional and observational studies that uMed are currently supporting below.
uMed Studies
-
Study Aim:
To help people live healthier lives for longer through the discovery and testing of more effective approaches to prevention, earlier detection and treatment of diseases.
-
Recruitment Target:
>150,000 patients including anyone over the age of 18
-
Treatment Area:
Parkinson's Disease
-
Study Aim:
To advance our understanding of Parkinson’s Disease and accelerate the development of advanced therapies to improve outcomes for patients.
-
Recruitment Target:
Ongoing patient recruitment of patient's diagnosed with Parkinson's Disease.
-
Treatment Area:
Parkinson's Disease
-
Study Aim:
To identify people at high risk of Parkinson’s before the symptoms appear.
-
Recruitment Target:
5,000 patients without a diagnosis of PD
-
Treatment Area:
Multiple Sclerosis
-
Study Aim:
To discover whether the genes that contribute to MS risk are the same or different for people of non-European ancestry, with a focus on people from African & South Asian backgrounds.
-
Recruitment Target:
400 patients
-
Trial Site Locations:
Poole, Bournemouth, Portsmouth & Southampton
-
Study Aim:
To help people live healthier lives for longer through the discovery and testing of more effective approaches to prevention, earlier detection and treatment of diseases.
-
Recruitment Target:
>150,000 patients including anyone over the age of 18
-
Treatment Area:
Respiratory Syncytial Virus (RSV)
-
Trial Site Locations:
Fylde Coast Clinical Research Blackpool, Royal Devon University Healthcare NHS Foundation Trust, Royal Free Hospital London
-
Study Aim:
To evaluate the safety and immune response of an investigational vaccine (mRNA-1345) aimed at preventing RSV infection in high risk adults
-
Recruitment Target:
100 patients
-
Treatment Area:
Parkinson's Disease
-
Trial Site Locations:
Newcastle University, Campus for Ageing and Vitality.
-
Study Aim:
This study, run by The Michael J. Fox Foundation for Parkinson’s Research, is exploring the link between loss of smell and brain disease by providing study participants with a simple scratch-and-sniff test.
-
Recruitment Target:
15,000 patients without Parkinson's Disease.
-
Treatment Area:
Alopecia Areata
-
Trial Site Locations:
Queen Anne Street Medical Centre, London
-
Study Aim:
To assess the safety, efficacy & dose response characterisation of STSO1 (Dithranol/ProSilic) administered topically, once daily, to affected scalp areas for 6 months, in patients who have mild to moderate Alopecia Areata.
-
Recruitment Target:
100 patients with mild to moderate Alopecia
-
Treatment Area:
Chronic Kidney Disease and Pruritus
-
Trial Site Locations:
The Royal London Hospital, Hull University Teaching Hospital, Newcastle Hospitals NHS Foundation Trust, Nottingham University Teaching Hospital, Churchill Hospital, Oxford University
-
Study Aim:
To evaluate the efficacy and safety of MC2-25 Cream and MC2-25 vehicle in subjects with chronic kidney disease-associated pruritus (CKD aP)
-
Recruitment Target:
22 Patients: Non-Dialysis CKD stage 3
22 Patients: Non-dialysis CKD stage 4/5
Total: 44 Patients
Hear from our current network...
Hear what patients think about uMed...